Indications and uses
relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain food and beverages
relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain food and beverages
adults and children 12 years and over: to relieve symptoms, swallow 1 tablet with a glass of water. Do not chew. to prevent symptoms, swallow 1 tablet with a glass of water at any time from 10 to 60 minutes before eating food or drinking beverages that cause heartburn do not use more than 2 tablets in 24 hours children under 12 years: ask a doctor
read the directions and warnings before use store at 20°-25°C (68°-77°F) keep the carton. It contains important information. protect from moisture
Drugs Facts
Allergy alert: Do not use if you are allergic to famotidine or other acid reducers
| Class | Version | Type | Effective |
|---|---|---|---|
| FAMOTIDINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0364679374054 | GTIN-13: 0364679374054 EAN-13: 0364679374054 GTIN-12: 364679374054 UPC-A: 364679374054 GTIN storage (14 digits): 00364679374054 | Famotidine 20 mg_OTC_500's Bottle Label.jpg, Famotidine 20 mg_OTC_500's Bottle Carton.jpg |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 396bde5c-c78e-2f8b-ab1f-2ee6ba32bcae | Product name | 7 | 20260317 |
| 1e73f975-1ce7-705e-2bcf-788b1b5e24ba | Product name | 5 | 20251124 |
| cf645750-2e70-f6e1-c05a-a52847def5dd | Product name | 9 | 20250312 |
| 4fdc761c-585e-054b-8ebe-86130a26e4c1 | Product name | 2 | 20221205 |
| fc2e1e31-353a-2c24-a4b4-fcf93bf7e38e | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55648-374-00 | 2019-11-13 | C162847 | 48780-1 | 97449f38-d0dc-f6ea-e053-dbdaa90aa703 | Famotidine Tablets, USP 20 mg |
| 55648-374-01 | 2019-11-13 | C162847 | 48780-1 | 97449f38-d0dc-f6ea-e053-dbdaa90aa703 | Famotidine Tablets, USP 20 mg |
| 55648-374-05 | 2019-11-13 | C162847 | 48780-1 | 97449f38-d0dc-f6ea-e053-dbdaa90aa703 | Famotidine Tablets, USP 20 mg |
| 55648-374-07 | 2019-11-13 | C162847 | 48780-1 | 97449f38-d0dc-f6ea-e053-dbdaa90aa703 | Famotidine Tablets, USP 20 mg |
| 55648-374-08 | 2019-11-13 | C162847 | 48780-1 | 97449f38-d0dc-f6ea-e053-dbdaa90aa703 | Famotidine Tablets, USP 20 mg |
| 55648-374-09 | 2019-11-13 | C162847 | 48780-1 | 97449f38-d0dc-f6ea-e053-dbdaa90aa703 | Famotidine Tablets, USP 20 mg |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55648-374-00 | FAMOTIDINE | 38000 in 1 DRUM | TABLET | 38000 | 2 | |
| 55648-374-01 | FAMOTIDINE | 1 in 1 CARTON | TABLET | 1 | 2 | |
| 55648-374-01 | FAMOTIDINE | 30 in 1 BOTTLE | TABLET | 30 | 2 | |
| 55648-374-05 | FAMOTIDINE | 1 in 1 CARTON | TABLET | 1 | 2 | |
| 55648-374-05 | FAMOTIDINE | 500 in 1 BOTTLE | TABLET | 500 | 2 | |
| 55648-374-07 | FAMOTIDINE | 10 in 1 CARTON | TABLET | 10 | 2 | |
| 55648-374-07 | FAMOTIDINE | 10 in 1 BLISTER PACK | TABLET | 10 | 2 | |
| 55648-374-08 | FAMOTIDINE | 1 in 1 CARTON | TABLET | 1 | 2 | |
| 55648-374-08 | FAMOTIDINE | 30 in 1 BOTTLE | TABLET | 30 | 2 | |
| 55648-374-09 | FAMOTIDINE | 6500 in 1 DRUM | TABLET | 6500 | 2 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| FAMOTIDINE | ACTIVE INGREDIENT | 5QZO15J2Z8 | 2 | |
| FAMOTIDINE | ACTIVE MOIETY | 5QZO15J2Z8 | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 2 | |
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | INACTIVE INGREDIENT | 2165RE0K14 | 2 | |
| HYPROMELLOSE 2910 (6 MPA.S) | INACTIVE INGREDIENT | 0WZ8WG20P6 | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 2 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | 2 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | 2 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 55648-374 | 55648-374-01, 55648-374-08, 55648-374-05, 55648-374-07, 55648-374-00, 55648-374-09 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| FAMOTIDINE | 5QZO15J2Z8 | ACTIB |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | 2165RE0K14 | IACT |
| TALC | 7SEV7J4R1U | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| HYPROMELLOSE 2910 (6 MPA.S) | 0WZ8WG20P6 | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
| POLYETHYLENE GLYCOL 400 | B697894SGQ | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / SUBLINGUAL | 17.5 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 1576 mg | ||
| HYPROMELLOSE 2910 (6 MPA.S) | HYPROMELLOSE 2910 (6 MPA.S) | 0WZ8WG20P6 | CAPSULE, EXTENDED RELEASE / ORAL | 232 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | SOLUTION / ORAL | 70200 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CREAM / TOPICAL | 80 mg | ||
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | 2165RE0K14 | TABLET / ORAL | 480 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | CAPSULE, DELAYED RELEASE / ORAL | 216 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, COATED / ORAL | 87 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | SPONGE / TOPICAL | NA | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / INTRAVITREAL | NA | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | SOAP / TOPICAL | 1 %w/w | ||
| TALC | TALC | 7SEV7J4R1U | SUSPENSION / ORAL | 234 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | SOLUTION, CONCENTRATE / ORAL | 2813 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 21 mg | ||
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | 2165RE0K14 | CAPSULE / ORAL | 150 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 19 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | INSERT, EXTENDED RELEASE / OPHTHALMIC | 0.4 mg | ||
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | 2165RE0K14 | TABLET, DELAYED RELEASE / ORAL | 103 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | LIQUID / TOPICAL | 1 %w/w | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / SUBLINGUAL | 32.4 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | SUSPENSION/ DROPS / ORAL | 90 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, EXTENDED RELEASE / ORAL | 184 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | GEL / TOPICAL | 6300 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, COATED PELLETS / ORAL | 456 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | LOTION / TOPICAL | NA | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | GRANULE / ORAL | 629 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 18 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | AEROSOL, POWDER / TOPICAL | NA | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, EXTENDED RELEASE / ORAL | 173 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | PASTE, DENTIFRICE / DENTAL | 0.4 %w/w | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | SUSPENSION / ORAL | 64 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | OINTMENT / TOPICAL | 1950 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, ORALLY DISINTEGRATING / ORAL | 6 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | TABLET, ORALLY DISINTEGRATING / ORAL | 2 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER / ORAL | 25 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 11 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, FOR SUSPENSION / ORAL | 278 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, ORALLY DISINTEGRATING / ORAL | 1800 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / BUCCAL | 15 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SUSPENSION / ORAL | 4441 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE / ORAL | 2169 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FOR SUSPENSION / ORAL | 131 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | EMULSION / TOPICAL | 1.2 %w/w | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | SUSPENSION, EXTENDED RELEASE / ORAL | 71 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | RING / VAGINAL | 2 mg | ||
| HYPROMELLOSE 2910 (6 MPA.S) | HYPROMELLOSE 2910 (6 MPA.S) | 0WZ8WG20P6 | TABLET, EXTENDED RELEASE / ORAL | 85 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE / ORAL | 729 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | SWAB / TOPICAL | 5250 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | SOLUTION/ DROPS / OPHTHALMIC | 1 %w/v | ||
| TALC | TALC | 7SEV7J4R1U | DROPS / ORAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, DELAYED RELEASE / ORAL | 789.6 mg | ||
| HYPROMELLOSE 2910 (6 MPA.S) | HYPROMELLOSE 2910 (6 MPA.S) | 0WZ8WG20P6 | TABLET, COATED / ORAL | 12 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, DELAYED RELEASE / ORAL | 66 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IMPLANT / INTRAVITREAL | 1.66 mg | ||
| TALC | TALC | 7SEV7J4R1U | GRANULE, FOR SUSPENSION / ORAL | 296 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, EXTENDED RELEASE / ORAL | 5119 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090837-001 | FAMOTIDINE | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A090837-001 | FAMOTIDINE | 20MG | TABLET / ORAL | 2010-08-04 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d0e9c888-c641-40a8-9338-d83b6de02385 | fdff466f-9884-4bbd-89af-0e186a54801b | 2012-08-07 | Warnings | d0e9c888-c641-40a8-9338-d83b6de02385 fdff466f-9884-4bbd-89af-0e186a54801b |
Adverse event summaries are temporarily unavailable. Other product information remains available.